BIO-Europe EBD Group BIO BIO-Europe
Share:
Email this page Share this on LinkedIn Share this on Twitter

BIO-Europe® 2014 Presenting Companies

2bind GmbH Germany Visit their website Connect on partnering360  
Next Generation - R&D service | 09:10, Wednesday, November 5 | Level VIA | Room Frequenz 2
4SC AG Germany Visit their website Connect on partnering360  
Cancer | 09:00, Wednesday, November 5 | Level 1 | Room Transparenz 1
Ability Pharmaceuticals Spain Visit their website Connect on partnering360  
Cancer | 16:45, Tuesday, November 4 | Level 1 | Room Transparenz 1
Absynth Biologics Ltd United Kingdom Visit their website Connect on partnering360  
Vaccines | 17:15, Tuesday, November 4 | Level 1 | Room Transparenz 2
ActoGeniX NV Belgium Visit their website Connect on partnering360  
Autoimmune/Inflammation | 14:30, Tuesday, November 4 | Level VIA | Room Frequenz 2
AFFiRiS AG Austria Visit their website Connect on partnering360  
Vaccines | 17:30, Tuesday, November 4 | Level 1 | Room Transparenz 2
Almirall Spain Visit their website Connect on partnering360  
Midsize Pharma | 16:00, Tuesday, November 4 | VIA | Room Frequenz 1
Alzprotect France Visit their website Connect on partnering360  
CNS/Neurology | 14:00, Tuesday, November 4 | Level 1 | Room Transparenz 1
amcure GmbH Germany Visit their website Connect on partnering360  
Next Generation | 16:40, Tuesday, November 4 | VIA | Room Frequenz 1
ANERGIS SA Switzerland Visit their website Connect on partnering360  
Respiratory | 11:15, Tuesday, November 4 | Level 1 | Room Transparenz 2
Antibe Therapeutics Inc. Canada Visit their website    
GI/Metabolic/Diabetes | 10:15, Tuesday, November 4 | Level 1 | Room Transparenz 1
Apogenix Germany Visit their website Connect on partnering360  
Cancer | 16:30, Tuesday, November 4 | Level 1 | Room Transparenz 1
Apricus Biosciences United States Visit their website Connect on partnering360  
Men´s and Women´s Health | 10:30, Tuesday, November 4 | Level 1 | Room Transparenz 2
arGEN-X Netherlands Visit their website    
Antibodies | 09:00, Wednesday, November 5 | Level VIA | Room Frequenz 1
Arisgen SA Switzerland Visit their website Connect on partnering360  
GI/Metabolic/Diabetes | 09:00, Tuesday, November 4 | Level 1 | Room Transparenz 1
Asceneuron SA Switzerland Visit their website Connect on partnering360  
CNS/Neurology | 10:10, Wednesday, November 5 | Level VIA | Room Frequenz 2
Avexxin AS Norway Visit their website Connect on partnering360  
Autoimmune/Inflammation | 14:00, Tuesday, November 4 | Level VIA | Room Frequenz 2
BBB Therapeutics Netherlands Visit their website Connect on partnering360  
Cancer | 11:30, Wednesday, November 5 | Level 1 | Room Transparenz 1
Biaffin GmbH Germany Visit their website Connect on partnering360  
Focus on Hessen | 14:00, Tuesday, November 4 | Level 1 | Room Transparenz 2
bioExpert Germany Visit their website Connect on partnering360  
CNS/Neurology | 14:15, Tuesday, November 4 | Level 1 | Room Transparenz 1
BioKier, Inc. United States Visit their website Connect on partnering360  
GI/Metabolic/Diabetes | 09:15, Tuesday, November 4 | Level 1 | Room Transparenz 1
BioMarin United States Visit their website Connect on partnering360  
Midsize Pharma | 14:00, Tuesday, November 4 | Level VIA | Room Frequenz 1
Bioneer A/S Denmark Visit their website Connect on partnering360  
Discovery Platform | 10:30, Wednesday, November 5 | Level VIA | Room Frequenz 1
BioNTech AG Germany Visit their website Connect on partnering360  
Cancer | 17:00, Tuesday, November 4 | Level 1 | Room Transparenz 1
Boehringer Ingelheim Pharma GmbH & Co. KG Germany Visit their website Connect on partnering360  
Service/CMO | 16:30, Tuesday, November 4 | Level VIA | Room Frequenz 2
Bone Therapeutics Belgium Visit their website Connect on partnering360  
Cell Therapy/Regenerative Medicine | 10:45, Tuesday, November 4 | Level 1 | Room Transparenz 1
Calypso Biotech SA Switzerland Visit their website Connect on partnering360  
Next Generation - GI/Metabolic/Diabetes | 10:30, Wednesday, November 5 | Level VIA | Room Frequenz 2
Canbex Therapeutics Ltd United Kingdom Visit their website    
Next Generation - CNS/Neurology | 10:00, Wednesday, November 5 | Level VIA | Room Frequenz 2
Cellectar Biosciences United States Visit their website Connect on partnering360  
Cancer | 11:45, Wednesday, November 5 | Level 1 | Room Transparenz 1
CELLIPSE France Visit their website Connect on partnering360  
Next Generation - Cancer | 09:40, Wednesday, November 5 | Level VIA | Room Frequenz 2
Cempra, Inc. United States Visit their website Connect on partnering360  
Infectious Disease | 09:15, Tuesday, November 4 | Level 1 | Room Transparenz 2
Cerecor Inc. United States Visit their website Connect on partnering360  
CNS/Neurology | 14:30, Tuesday, November 4 | Level 1 | Room Transparenz 1
CEVEC Pharmaceuticals GmbH Germany Visit their website Connect on partnering360  
Service/CMO | 16:45, Tuesday, November 4 | Level VIA | Room Frequenz 2
Chiome Bioscience Inc. Japan Visit their website Connect on partnering360  
Discovery Platform | 10:45, Wednesday, November 5 | Level VIA | Room Frequenz 1
Chugai Pharmaceutical Co., Ltd. Japan Visit their website Connect on partnering360  
Midsize Pharma | 14:15, Tuesday, November 4 | Level VIA | Room Frequenz 1
Ci3 Management UG Germany Visit their website Connect on partnering360  
Autoimmune/Inflammation | 15:15, Tuesday, November 4 | Level VIA | Room Frequenz 2
Cincinnati Children's Hospital Medical Center United States Visit their website Connect on partnering360  
Academic Innovators | 15:00, Tuesday, November 4 | Level 1 | Room Transparenz 2
Comprehensive Biomarker Center GmbH Germany Visit their website Connect on partnering360  
Next Generation - Biomarkers/Diagnostics/Imaging | 09:50, Wednesday, November 5 | Level VIA | Room Frequenz 2
Cormorant Pharmaceuticals Sweden Visit their website Connect on partnering360  
Next Generation - Cancer | 09:20, Wednesday, November 5 | Level VIA | Room Frequenz 2
Critical Outcome Technologies Inc. Canada Visit their website Connect on partnering360  
Discovery Platform | 11:15, Wednesday, November 5 | Level VIA | Room Frequenz 1
Curasight Denmark Visit their website    
Biomarkers/Diagnostics/Imaging | 11:00, Wednesday, November 5 | Level VIA | Room Frequenz 2
CureVac GmbH Germany Visit their website Connect on partnering360  
Vaccines | 17:00, Tuesday, November 4 | Level 1 | Room Transparenz 2
Cytonet GmbH & Co. KG Germany Visit their website Connect on partnering360  
Cell Therapy/Regenerative Medicine | 10:30, Tuesday, November 4 | Level 1 | Room Transparenz 1
CytoTools AG Germany Visit their website Connect on partnering360  
Focus on Hessen | 14:00, Tuesday, November 4 | Level 1 | Room Transparenz 2
Debiopharm International S.A. Switzerland Visit their website Connect on partnering360  
Midsize Pharma | 14:30, Tuesday, November 4 | Level VIA | Room Frequenz 1
DR. KADE Pharmazeutische Fabrik GmbH Germany Visit their website Connect on partnering360  
Midsize Pharma | 14:45, Tuesday, November 4 | Level VIA | Room Frequenz 1
Epigenomics AG Germany Visit their website Connect on partnering360  
Biomarkers/Diagnostics/Imaging | 11:30, Wednesday, November 5 | Level VIA | Room Frequenz 2
ERYTECH France Visit their website Connect on partnering360  
Cancer | 17:15, Tuesday, November 4 | Level 1 | Room Transparenz 1
EUFETS GmbH Germany Visit their website Connect on partnering360  
Service/CMO | 17:00, Tuesday, November 4 | Level VIA | Room Frequenz 2
Eyevensys France Visit their website Connect on partnering360  
Ophthalmology | 11:45, Wednesday, November 5 | Level VIA | Room Frequenz 2
Gallus BioPharmaceuticals United States Visit their website Connect on partnering360  
Service/CMO | 17:15, Tuesday, November 4 | Level VIA | Room Frequenz 2
Genable Technologies Ireland Visit their website    
RNA Therapeutics/Gene Therapy | 12:00, Wednesday, November 5 | Level VIA | Room Frequenz 1
Gene Signal SA Switzerland Visit their website Connect on partnering360  
Ophthalmology | 12:00, Wednesday, November 5 | Level VIA | Room Frequenz 2
GENFIT France Visit their website Connect on partnering360  
GI/Metabolic/Diabetes | 09:30, Tuesday, November 4 | Level 1 | Room Transparenz 1
Genmab Denmark Visit their website Connect on partnering360  
Antibodies | 09:15, Wednesday, November 5 | Level VIA | Room Frequenz 1
GenXPro GmbH Germany Visit their website Connect on partnering360  
Focus on Hessen | 14:00, Tuesday, November 4 | Level 1 | Room Transparenz 2
Goethe University Germany Visit their website    
Academic Innovators | 16:10, Tuesday, November 4 | Level 1 | Room Transparenz 2
Goethe University Germany Visit their website    
Academic Innovators | 16:20, Tuesday, November 4 | Level 1 | Room Transparenz 2
Grünenthal Germany Visit their website Connect on partnering360  
Midsize Pharma | 15:00, Tuesday, November 4 | Level VIA | Room Frequenz 1
Haisco Pharmaceutical Group Co., Ltd China Visit their website Connect on partnering360  
Midsize Pharma | 15:15, Tuesday, November 4 | Level VIA | Room Frequenz 1
Haplogen GmbH Austria Visit their website Connect on partnering360  
Infectious Disease | 10:00, Tuesday, November 4 | Level 1 | Room Transparenz 2
Heptares Therapeutics Ltd United Kingdom Visit their website Connect on partnering360  
CNS/Neurology | 14:45, Tuesday, November 4 | Level 1 | Room Transparenz 1
Herantis Pharma Finland Visit their website    
Ophthalmology | 12:15, Wednesday, November 5 | Level VIA | Room Frequenz 2
HoneyLab New Zealand Visit their website Connect on partnering360  
Next Generation - Autoimmune/Inflammation | 10:20, Wednesday, November 5 | Level VIA | Room Frequenz 2
Horizon Pharma United States Visit their website Connect on partnering360  
Midsize Pharma | 15:30, Tuesday, November 4 | Level VIA | Room Frequenz 1
Hovione United States Visit their website Connect on partnering360  
Delivery | 12:30, Wednesday, November 5 | Level VIA | Room Frequenz 2
imec Belgium Visit their website    
Academic Innovators | 15:10, Tuesday, November 4 | Level 1 | Room Transparenz 2
Innovent Biologics, Inc. China Visit their website Connect on partnering360  
Antibodies | 09:30, Wednesday, November 5 | Level VIA | Room Frequenz 1
Inovio Pharmaceuticals United States Visit their website Connect on partnering360  
Vaccines | 17:45, Tuesday, November 4 | Level 1 | Room Transparenz 2
Intec Pharma Israel Visit their website Connect on partnering360  
Delivery | 12:45, Wednesday, November 5 | Level VIA | Room Frequenz 2
Interceptin Italy Visit their website Connect on partnering360  
Next Generation - Cancer | 09:30, Wednesday, November 5 | Level VIA | Room Frequenz 2
Isofol Medical AB Sweden Visit their website Connect on partnering360  
Cancer | 17:30, Tuesday, November 4 | Level 1 | Room Transparenz 1
Jortan Pharmaceuticals United States Visit their website Connect on partnering360  
Next Generation | 09:00, Wednesday, November 5 | Level VIA | Room Frequenz 2
K-Stemcell Co Ltd Korea, South Visit their website    
Cell Therapy/Regenerative Medicine | 11:00, Tuesday, November 4 | Level 1 | Room Transparenz 1
Kyoto Constella Technologies Japan Visit their website Connect on partnering360  
Discovery Platform | 11:00, Wednesday, November 5 | Level VIA | Room Frequenz 1
Lipopharma Therapeutics Spain Visit their website Connect on partnering360  
Next Generation | 16:50, Tuesday, November 4 | Level VIA | Room Frequenz 1
Lonza Switzerland Visit their website Connect on partnering360  
Service/CMO | 16:15, Tuesday, November 4 | Level VIA | Room Frequenz 2
Marina Biotech, Inc. United States Visit their website Connect on partnering360  
RNA Therapeutics/Gene Therapy | 11:30, Wednesday, November 5 | Level VIA | Room Frequenz 1
MaxCyte, Inc. United States Visit their website Connect on partnering360  
RNA Therapeutics/Gene Therapy | 12:15, Wednesday, November 5 | Level VIA | Room Frequenz 1
McGill University Canada Visit their website Connect on partnering360  
Academic Innovators | 15:20, Tuesday, November 4 | Level 1 | Room Transparenz 2
MediVector, Inc. United States Visit their website Connect on partnering360  
Infectious Disease | 09:30, Tuesday, November 4 | Level 1 | Room Transparenz 2
Merck Millipore Germany Visit their website Connect on partnering360  
Midsize Pharma | 15:45, Tuesday, November 4 | Level VIA | Room Frequenz 1
MetaHeps GmbH Germany Visit their website Connect on partnering360  
Next Generation | 10:50, Wednesday, November 5 | Level VIA | Room Frequenz 2
Metys Pharmaceuticals Switzerland Visit their website Connect on partnering360  
CNS/Neurology | 15:00, Tuesday, November 4 | Level 1 | Room Transparenz 1
Midas Pharma Germany Visit their website Connect on partnering360  
Antibodies | 09:45, Wednesday, November 5 | Level VIA | Room Frequenz 1
Moberg Pharma Sweden Visit their website Connect on partnering360  
Midsize Pharma | 16:15, Tuesday, November 4 | Level VIA | Room Frequenz 1
MRC TECHNOLOGY LTD United Kingdom Visit their website Connect on partnering360  
Academic Innovators | 15:30, Tuesday, November 4 | Level 1 | Room Transparenz 2
NANOMI Netherlands Visit their website Connect on partnering360  
Next Generation | 10:40, Wednesday, November 5 | Level VIA | Room Frequenz 2
NB Health Laboratory Co. Ltd. Japan Visit their website Connect on partnering360  
Antibodies | 10:00, Wednesday, November 5 | Level VIA | Room Frequenz 1
NeoStem, Inc. United States Visit their website Connect on partnering360  
Cell Therapy | 11:15, Tuesday, November 4 | Level 1 | Room Transparenz 1
Neovacs France Visit their website Connect on partnering360  
Autoimmune/Inflammation | 15:00, Tuesday, November 4 | Level VIA | Room Frequenz 2
NephroGenex United States Visit their website Connect on partnering360  
GI/Metabolic/Diabetes | 09:45, Tuesday, November 4 | Level 1 | Room Transparenz 1
Northwestern University - Feinberg School of Medicine United States Visit their website Connect on partnering360  
Academic Innovators | 15:40, Tuesday, November 4 | Level 1 | Room Transparenz 2
NOXXON Pharma AG Germany Visit their website Connect on partnering360  
Cancer | 17:45, Tuesday, November 4 | Level 1 | Room Transparenz 1
ObsEva SA Switzerland Visit their website    
Obstetrics/Gynecology | 10:45, Tuesday, November 4 | Level 1 | Room Transparenz 2
Oncopeptides AB Sweden Visit their website Connect on partnering360  
Cancer | 09:30, Wednesday, November 5 | Level 1 | Room Transparenz 1
Oncos Therapeutics Ltd. Finland Visit their website Connect on partnering360  
Cancer | 09:15, Wednesday, November 5 | Level 1 | Room Transparenz 1
OncoSec Medical, Inc. United States Visit their website Connect on partnering360  
Immunotherapy | 11:30, Tuesday, November 4 | Level 1 | Room Transparenz 2
Oncothyreon Inc. United States Visit their website Connect on partnering360  
Cancer | 12:00, Wednesday, November 5 | Level 1 | Room Transparenz 1
ONXEO France Visit their website    
Cancer | 12:15, Wednesday, November 5 | Level 1 | Room Transparenz 1
ORYX Translational Medicine Germany Visit their website Connect on partnering360  
Cancer | 09:45, Wednesday, November 5 | Level 1 | Room Transparenz 1
Oxford Pharmascience Group Plc United Kingdom Visit their website Connect on partnering360  
Next Generation | 17:00, Tuesday, November 4 | Level VIA | Room Frequenz 1
OXIGENE United States Visit their website Connect on partnering360  
Cancer | 10:00, Wednesday, November 5 | Level 1 | Room Transparenz 1
Oxyrane Belgium Visit their website Connect on partnering360  
Orphan Disease | 10:15, Tuesday, November 4 | Level 1 | Room Transparenz 2
Peregrine Pharmaceuticals, Inc United States Visit their website Connect on partnering360  
Cancer | 10:15, Wednesday, November 5 | Level 1 | Room Transparenz 1
PIQUR Therapeutics AG Switzerland Visit their website Connect on partnering360  
Cancer | 10:30, Wednesday, November 5 | Level 1 | Room Transparenz 1
PledPharma AB Sweden Visit their website Connect on partnering360  
Cancer | 10:45, Wednesday, November 5 | Level 1 | Room Transparenz 1
Principia Biopharma United States Visit their website Connect on partnering360  
Autoimmune/Inflammation | 14:15, Tuesday, November 4 | Level VIA | Room Frequenz 2
ProFactor Pharma Ltd United Kingdom Visit their website Connect on partnering360  
Next Generation | 17:10, Tuesday, November 4 | Level VIA | Room Frequenz 1
PTC Therapeutics, Inc. United States Visit their website Connect on partnering360  
Genetic Disorders | 11:00, Tuesday, November 4 | Level 1 | Room Transparenz 2
Radius Health, Inc. United States Visit their website Connect on partnering360  
Cancer | 12:45, Wednesday, November 5 | Level 1 | Room Transparenz1
Randox Laboratories United Kingdom Visit their website Connect on partnering360  
Antibodies | 10:15, Wednesday, November 5 | Level VIA | Room Frequenz 1
RedHill Biopharma Israel Visit their website Connect on partnering360  
GI/Metabolic/Diabetes | 10:00, Tuesday, November 4 | Level 1 | Room Transparenz 1
REGiMMUNE Corporation Japan Visit their website Connect on partnering360  
Autoimmune/Inflammation | 14:45, Tuesday, November 4 | Level VIA | Room Frequenz 2
Rentschler Biotechnologie GmbH Germany Visit their website Connect on partnering360  
Service/CMO | 17:30, Tuesday, November 4 | Level VIA | Room Frequenz 2
Resverlogix Corp. Canada Visit their website Connect on partnering360  
Cardiovascular | 15:30, Tuesday, November 4 | Level VIA | Room Frequenz 2
Rexahn Pharmaceuticals United States Visit their website Connect on partnering360  
Cancer | 11:00, Wednesday, November 5 | Level 1 | Room Transparenz 1
Rigontec GmbH Germany Visit their website Connect on partnering360  
Next Generation | 17:20, Tuesday, November 4 | Level VIA | Room Frequenz 1
Sanifit Spain Visit their website Connect on partnering360  
Cardiovascular | 15:45, Tuesday, November 4 | Level VIA | Room Frequenz 2
Santhera Pharmaceuticals Switzerland Visit their website Connect on partnering360  
CNS/Neurology | 15:15, Tuesday, November 4 | Level 1 | Room Transparenz 1
Selvita SA Poland Visit their website Connect on partnering360  
Cancer | 11:15, Wednesday, November 5 | Level 1 | Room Transparenz 1
SFC Co., Ltd Korea, South Visit their website Connect on partnering360  
Biomarkers/Diagnostics/Imaging | 11:15, Wednesday, November 5 | Level VIA | Room Frequenz 2
SOM Biotech Spain Visit their website Connect on partnering360  
CNS/Neurology | 15:30, Tuesday, November 4 | Level 1 | Room Transparenz 1
SpeeDx Pty Ltd Australia Visit their website Connect on partnering360  
Enabling Technologies | 11:15, Tuesday, November 4 | Level VIA | Room Frequenz 2
Stemmatters SA Portugal Visit their website Connect on partnering360  
Cell Therapy/Regenerative Medicine | 11:30, Tuesday, November 4 | Level 1 | Room Transparenz 1
Synereca Pharmaceuticals United States Visit their website Connect on partnering360  
Next Generation | 17:30, Tuesday, November 4 | Level VIA | Room Frequenz 1
Synthetic Biologics, Inc. United States Visit their website Connect on partnering360  
Infectious Disease | 09:45, Tuesday, November 4 | Level 1 | Room Transparenz 2
Takis Italy Visit their website Connect on partnering360  
Cancer | 12:30, Wednesday, November 5 | Level 1 | Room Transparenz 1
TauRx Pharmaceuticals Ltd. United Kingdom Visit their website    
CNS/Neurology | 15:45, Tuesday, November 4 | Level 1 | Room Transparenz 1
TI Pharma Netherlands Visit their website Connect on partnering360  
Academic Innovators | 16:30, Tuesday, November 4 | Level 1 | Room Transparenz 2
TIGO GmbH Germany Visit their website Connect on partnering360  
Focus on Hessen | 14:00, Tuesday, November 4 | Level 1 | Room Transparenz 2
TTFactor srl Italy Visit their website Connect on partnering360  
Academic Innovators | 15:50, Tuesday, November 4 | Level 1 | Room Transparenz 2
UCB Belgium Visit their website Connect on partnering360  
CNS/Neurology | 16:00, Tuesday, November 4 | Level 1 | Room Transparenz 1
University of Wuerzburg - SmartmAb Germany Visit their website Connect on partnering360  
Academic Innovators | 16:00, Tuesday, November 4 | Level 1 | Room Transparenz 2
Vela Singapore Visit their website Connect on partnering360  
Cancer | 16:15, Tuesday, November 4 | Level 1 | Room Transparenz 1
Vetter Pharma International Germany Visit their website Connect on partnering360  
Service/CMO | 16:00, Tuesday, November 4 | Level VIA | Room Frequenz 2
Wacker Biotech GmbH Germany Visit their website Connect on partnering360  
Service/CMO | 17:45, Tuesday, November 4 | Level VIA | Room Frequenz 2
XL-protein GmbH Germany Visit their website Connect on partnering360  
Enabling Technologies | 11:30, Tuesday, November 4 | Level VIA | Room Frequenz 2
Zai Laboratory China Visit their website Connect on partnering360  
Next Generation | 17:40, Tuesday, November 4 | Level VIA | Room Frequenz 1
Zedira Germany Visit their website Connect on partnering360  
Focus on Hessen | 14:00, Tuesday, November 4 | Level 1 | Room Transparenz 2
Arrow Up


© 2009–2014 EBD GmbH
BIO-Europe EBD Group BIO BIO-Europe